BBIO Message Board Post 10031384 | BridgeBio Pharma Inc.
home / stock / bbio / bbio message board
Kufie_Smack
(investorshub)
Posted on: May/13/2022 11:57:26
Source: investorshub
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=168847686
BridgeBio Pharma Reports Sale Of Rare Pediatric Disease
News, Short Squeeze, Breakout and More Instantly...
BridgeBio Pharma Inc. Company Name:
BBIO Stock Symbol:
Market:
-
- Acoramidis treatment resulted in increased serum transthyretin (TTR) levels by Day 28 that were sustained and were correlated with a reduced risk of all-cause mortality (ACM), cardiovascular mortality (CVM), and cardiovascular-related hospitalization (CVH) in ATTR-CM participants through m...
-
2024-05-28 07:00:15 ET Eliana Merle from UBS issued a price target of $47.00 for BBIO on 2024-05-28 05:24:00. The adjusted price target was set to $47.00. At the time of the announcement, BBIO was trading at $27.94. The overall price target consensus is at $32.25 with hi...
-
- BridgeBio to host investor call on Wednesday, May 29, 2024 at 5:30 pm ET, with presentations from Mathew Maurer, M.D. of Columbia University Irving Medical Center, U.S. and Ahmad Masri, M.D., M.S. of Oregon Health & Science University, U.S. PALO ALTO, Calif., May 24, 2024 (GLOBE NEW...